Riabni (rituximab-arrx) is used to treat
rheumatoid arthritis,
leukemia, and non-hodgkin's
lymphoma. Riabni is a biosimilar for
rituxan (rituximab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Riabni may be covered by your Medicare or insurance plan. With the Patient Assistance Program from Genentech, you can receive your medication at no cost.
